Home > NRC Library > ADAMS Public Documents

Addl response to FOIA request for documents associated w/ investigation of Nuclear Pharmacy,Inc by Ofcs of Inspector & Auditor & IE.Forwards documents listed in Apps A & B.Info partially withheld (ref FOIA Exemptions 5 & 7).

Accession Number: ML20023A415

Date Released: Thursday, October 24, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20023C783 - Addl response to FOIA request for documents associated w/ investigation of Nuclear Pharmacy,Inc by Ofcs of Inspector & Auditor & IE.Forwards documents listed in Apps A & B.Info partially withheld (ref FOIA Exemptions 5 & 7). (7 page(s), 4/12/1983)
• ML20023C847 - Discusses 800128 interview w/J Murray re 800121 meeting w/ Nuclear Pharmacy,Inc on proposed notice of violation. (3 page(s), 2/4/1981)
• ML20023C831 - Confirms 791205 telcon re withdrawal of Nuclear Pharmacy,Inc matter from consideration by DOJ.Investigation of source of unauthorized disclosures of confidential info requested. (1 page(s), 12/7/1979)
• ML20023C873 - Forwards DOJ 800307 ltr describing frustrations in dealing w/NRC during consideration of possible criminal aspects of Nuclear Pharmacy,Inc case. (1 page(s), 3/13/1980)
• ML20023C842 - Discusses status of other NRC ofc actions from 790614-1127 re NRC criminal referral to DOJ re allegations of improper activities by Nuclear Pharmacy,Inc. (5 page(s), 12/13/1979)
• ML20023C890 - Notifies that original 800319 statement placed in Nuclear Pharmacy,Inc file on 800404.Personally identifiable info deleted. (15 page(s), 4/4/1980)
• ML20023C788 - Discusses 800129 interview w/JH Sniezek re 800121 meeting w/Nuclear Pharmacy,Inc concerning notice of violation. (4 page(s), 1/31/1980)
• ML20023C909 - Forwards Nuclear Pharmacy,Inc 800626 ltr discussing actions initiated to provide max safety for employees. (1 page(s), 7/7/1980)
• ML20023C795 - Forwards Region III 791102 ltr sent to certain customers (hosps) of Nuclear Pharmacy,Inc (NPI) notifying that NPI sold Xe-133 prepared from chemical-grade bulk matl rather than from pharm-grade bulk matl. (1 page(s), 11/6/1979)
• ML20023C822 - Application to amend License 24-16519-01,reflecting corporate name change to Nuclear Pharmacy,Inc & change of address. (1 page(s), 3/18/1977)
• ML20023C866 - Confirms 800227 telcon re Jan 1979 insp at Nuclear Pharmacy, Inc (NPI).No indication that NPI reused New England Nuclear dose vials for packaging & distributing Xe-133 observed. Interview rept encl.Personally identifiable info deleted. (9 page(s), 2/27/1980)
• ML20023C864 - Discusses 800109 ltr re pending administration action against Nuclear Pharmacy,Inc (NPI).DOJ currently reviewing matter.No operating restrictions placed on licensee. (1 page(s), 2/11/1980)
• ML20023C876 - Disagrees w/800313 memo to Chairman re civil penalties resulting from notice of violation issued to Nuclear Pharmacy,Inc. (2 page(s), 3/18/1980)
• ML20023C901 - Notifies that 800516 statements placed in Nuclear Pharmacy, Inc file on 800603.Personally identifiable info deleted. (13 page(s), 6/3/1980)
• ML20023C908 - Forwards Amend 6 to Matl Byproduct License 48-17466-01MD. License may be subj to subsequent action by NRC or DOJ resulting from exam of past activities involving Xe-133. Personally identifiable info deleted. (32 page(s), 5/3/1980)
• ML20023C899 - Discusses corrective actions per 800310 ltr,in response to NRC 800407 & 0219 ltrs re radiation safety for personnel.Mar film badge results indicate significant improvement. Personally identifiable info deleted. (2 page(s), 5/5/1980)
• ML20023C835 - Documents recollection of 790323 enforcement mgt meeting re Nuclear Pharmacy,Inc reason for distributing Union Carbide Xe-133. (1 page(s), 12/10/1979)
• ML20023C786 - Documents basis for certain statements contained in IE Insp Rept 79-01 for Nuclear Pharmacy,Inc.Personally identifiable info deleted. (3 page(s), 9/21/1979)
• ML20023C858 - Urges final action to resolve notice of violation issued to Nuclear Pharmacy,Inc in Aug 1979.Review by another agency not sufficient justification to forestall prompt action. (2 page(s), 1/9/1980)
• ML20023C914 - Forwards six interview summaries prepared by Region III re apparent conflict of interest by former Region I employee concerning Nuclear Pharmacy,Inc investigation.Personally identifiable info deleted. (10 page(s), 11/25/1980)
• ML20023C851 - Discusses Senator H Schmitt 800102 ltr re Nuclear Pharmacy, Inc (NPI) & T Brockett responses concerning possible criminal violations by NPI. (1 page(s), 2/19/1980)
• ML20023C809 - Urges NRC not to mitigate fine for Nuclear Pharmacy,Inc,re unauthorized acquisition & breakdown of packaging & delivery of Xe-133 unfit for human use.Other vendor violations cited. Personally identifiable info deleted. (3 page(s), 12/1/1979)
• ML20023C868 - Notifies that D Leggett & J Fischer provided w/listed statements during 800310 visit,per DOJ instructions re Nuclear Pharmacy,Inc investigation.Personally identifiable info deleted. (1 page(s), 3/13/1980)
• ML20023C816 - Submits amended response to 750410 questions re license application.Manufacturers package insert for all radiopharms dispensed by use will be forwarded to each user. (3 page(s), 4/23/1975)
• ML20023C885 - Notifies that final rept of 800401 interview placed in Nuclear Pharmacy,Inc statement file on 800404.Personally identifiable info deleted. (11 page(s), 4/4/1980)
• ML20023C792 - Discusses 800129 interview w/PE Baci (DOJ) re 800121 meeting between Nuclear Pharmacy,Inc (NPI) & NRC concerning NPI possession of Xe-133. (8 page(s), 2/1/1980)
• ML20023C799 - Discusses 791108 meeting w/DOJ re potential for developing prosecutable case against Nuclear Pharmacy,Inc.DOJ has no interest in proceeding w/criminal action if violation not of sufficient significance to warrant civil penalty. (2 page(s), 11/13/1979)
• ML20023C850 - Discusses 800205 interview w/V Stello re 800121 meeting w/ Nuclear Pharmacy,Inc concerning sales of Xe-133 not approved for human use.Affidavit encl.Personally identifiable info deleted. (6 page(s), 2/8/1981)
• ML20023C913 - Forwards documents on investigation of Nuclear Pharmacy,Inc (NPI) per 800827 commitment re NPI-Milwaukee distribution of non-NDA Xenon in willful violation of license condition. Personally identifiable info deleted.W/o encls. (3 page(s), 9/19/1980)
• ML20023C827 - Discusses 791207 telcon re postponement of meeting w/Nuclear Pharmacy,Inc (NPI).Allegations in notice of violation w/o foundation.Prompt action to resolve matter requested. (3 page(s), 12/7/1979)
• ML20023C845 - Forwards 791201 ltr re allegations of improper activities by Nuclear Pharmacy,Inc.Ltr includes number of issues which appear to warrant further investigation.Personally identifiable info deleted. (3 page(s), 12/19/1979)
• ML20023C870 - Advises that listed original statements placed in Nuclear Pharmacy,Inc investigation file on 800313.Personally identifiable info deleted. (1 page(s), 3/13/1980)
• ML20023C854 - Requests expeditious resolution of notice of violation issued to Nuclear Pharmacy,Inc. (1 page(s), 1/2/1980)
• ML20023A414 - Informs that Nuclear Pharmacy,Inc shipped Xe-133 unit doses not fit for human use.List of shipments,date distributed, activity & prescription number encl. (2 page(s), 11/2/1979)
• ML20023C894 - Discusses conflict of interest on part of former Region I employee re civil penalty action against Elfreth Alley Apothecary,part of Nuclear Pharmacy,Inc.Personally identifiable info deleted. (1 page(s), 5/29/1980)
• ML20023C910 - Discusses 800624 meeting re development of corporate radiation safety program.Personally identifiable info deleted. (4 page(s), 6/26/1980)
• ML20023C815 - Documents recollections of statements made during 790323 mgt enforcement conference re procurement & distribution of Union Carbon Xe-133 contrary to FDA & NRC requirements. (2 page(s), 12/5/1979)
• ML20023C803 - Discusses 791108 briefing w/DOJ re deficiencies in case against Nuclear Pharmacy,Inc concerning purchase of Xe-133 from Union Carbide. (2 page(s), 11/14/1979)
• ML20023C880 - Discusses 800321 telcon w/former employee of Nuclear Pharmacy,Inc,re unsafe & unethical practices.Interview encl. Personally identifiable info deleted. (7 page(s), 3/31/1980)